Ácido poli(láctico-co-glicólico) (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ácido poli(láctico-co-glicólico)" in Spanish language version.

refsWebsite

Global rank Spanish rank

14doi.org

2^nd place

13nih.gov

4^th place

6semanticscholar.org

11^th place

79^th place

1issn.org

57^th place

3^rd place

1books.google.com

3^rd place

7^th place

1restore-surgical.co.uk

low place

1medicalnewstoday.com

3,011^th place

3,464^th place

books.google.com

Wnek GE, Bowlin GL (28 de mayo de 2008). Encyclopedia of Biomaterials and Biomedical Engineering (en inglés). CRC Press. ISBN 978-1-4987-6143-7.

doi.org

dx.doi.org

Abulateefeh SR (February 2023). «Long-acting injectable PLGA/PLA depots for leuprolide acetate: successful translation from bench to clinic». Drug Delivery and Translational Research 13 (2): 520-530. PMID 35976565. S2CID 251622670. doi:10.1007/s13346-022-01228-0.
Astete CE, Sabliov CM (2006). «Synthesis and characterization of PLGA nanoparticles». Journal of Biomaterials Science. Polymer Edition 17 (3): 247-289. PMID 16689015. S2CID 7607080. doi:10.1163/156856206775997322.
Samadi N, Abbadessa A, Di Stefano A, van Nostrum CF, Vermonden T, Rahimian S, Teunissen EA, van Steenbergen MJ, Amidi M, Hennink WE (December 2013). «The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles». Journal of Controlled Release 172 (2): 436-443. PMID 23751568. doi:10.1016/j.jconrel.2013.05.034.
Pavot V, Berthet M, Rességuier J, Legaz S, Handké N, Gilbert SC, Paul S, Verrier B (December 2014). «Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery». Nanomedicine 9 (17): 2703-2718. PMID 25529572. doi:10.2217/nnm.14.156.
Crotts G, Park TG (2 de julio de 1998). «Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues». Journal of Microencapsulation 15 (6): 699-713. PMID 9818948. doi:10.3109/02652049809008253.
Zolnik BS, Burgess DJ (October 2007). «Effect of acidic pH on PLGA microsphere degradation and release». Journal of Controlled Release 122 (3): 338-344. PMID 17644208. doi:10.1016/j.jconrel.2007.05.034.
Fu K, Pack DW, Klibanov AM, Langer R (January 2000). «Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres». Pharmaceutical Research 17 (1): 100-106. PMID 10714616. S2CID 22378621. doi:10.1023/A:1007582911958.
Elmowafy EM, Tiboni M, Soliman ME (July 2019). «Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles». Journal of Pharmaceutical Investigation (en inglés) 49 (4): 347-380. ISSN 2093-6214. S2CID 256338815. doi:10.1007/s40005-019-00439-x.
Mir M, Ahmed N, Rehman AU (November 2017). «Recent applications of PLGA based nanostructures in drug delivery». Colloids and Surfaces. B, Biointerfaces 159: 217-231. PMID 28797972. doi:10.1016/j.colsurfb.2017.07.038.
Machatschek R, Lendlein A (March 2020). «Fundamental insights in PLGA degradation from thin film studies». Journal of Controlled Release 319: 276-284. PMID 31884098. S2CID 209511941. doi:10.1016/j.jconrel.2019.12.044.
Ramot Y, Haim-Zada M, Domb AJ, Nyska A (December 2016). «Biocompatibility and safety of PLA and its copolymers». Advanced Drug Delivery Reviews. PLA biodegradable polymers 107: 153-162. PMID 27058154. doi:10.1016/j.addr.2016.03.012.
Sasaki JI, Abe GL, Li A, Thongthai P, Tsuboi R, Kohno T, Imazato S (May 2021). «Barrier membranes for tissue regeneration in dentistry». Biomaterial Investigations in Dentistry 8 (1): 54-63. PMC 8158285. PMID 34104896. doi:10.1080/26415275.2021.1925556.
Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, Soh BK, Yoon G, Yu D, Yun Y, Lee BK, Jiang X, Wang Y (June 2019). «Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation». Journal of Controlled Release 304: 125-134. PMID 31071374. S2CID 149444044. doi:10.1016/j.jconrel.2019.05.003.
Xiao Q, Zhang H, Wu X, Qu J, Qin L, Wang C (2022). «Augmented Renal Clearance in Severe Infections-An Important Consideration in Vancomycin Dosing: A Narrative Review». Frontiers in Pharmacology 13: 835557. PMC 8979486. PMID 35387348. doi:10.3389/fphar.2022.835557.

issn.org

portal.issn.org

Elmowafy EM, Tiboni M, Soliman ME (July 2019). «Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles». Journal of Pharmaceutical Investigation (en inglés) 49 (4): 347-380. ISSN 2093-6214. S2CID 256338815. doi:10.1007/s40005-019-00439-x.

medicalnewstoday.com

Fletcher J (6 de marzo de 2023). «Lupron (leuprolide acetate) for prostate cancer: What to expect». www.medicalnewstoday.com (en inglés). Consultado el 30 de abril de 2023.

nih.gov

ncbi.nlm.nih.gov

Abulateefeh SR (February 2023). «Long-acting injectable PLGA/PLA depots for leuprolide acetate: successful translation from bench to clinic». Drug Delivery and Translational Research 13 (2): 520-530. PMID 35976565. S2CID 251622670. doi:10.1007/s13346-022-01228-0.
Astete CE, Sabliov CM (2006). «Synthesis and characterization of PLGA nanoparticles». Journal of Biomaterials Science. Polymer Edition 17 (3): 247-289. PMID 16689015. S2CID 7607080. doi:10.1163/156856206775997322.
Samadi N, Abbadessa A, Di Stefano A, van Nostrum CF, Vermonden T, Rahimian S, Teunissen EA, van Steenbergen MJ, Amidi M, Hennink WE (December 2013). «The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles». Journal of Controlled Release 172 (2): 436-443. PMID 23751568. doi:10.1016/j.jconrel.2013.05.034.
Pavot V, Berthet M, Rességuier J, Legaz S, Handké N, Gilbert SC, Paul S, Verrier B (December 2014). «Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery». Nanomedicine 9 (17): 2703-2718. PMID 25529572. doi:10.2217/nnm.14.156.
Crotts G, Park TG (2 de julio de 1998). «Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues». Journal of Microencapsulation 15 (6): 699-713. PMID 9818948. doi:10.3109/02652049809008253.
Zolnik BS, Burgess DJ (October 2007). «Effect of acidic pH on PLGA microsphere degradation and release». Journal of Controlled Release 122 (3): 338-344. PMID 17644208. doi:10.1016/j.jconrel.2007.05.034.
Fu K, Pack DW, Klibanov AM, Langer R (January 2000). «Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres». Pharmaceutical Research 17 (1): 100-106. PMID 10714616. S2CID 22378621. doi:10.1023/A:1007582911958.
Mir M, Ahmed N, Rehman AU (November 2017). «Recent applications of PLGA based nanostructures in drug delivery». Colloids and Surfaces. B, Biointerfaces 159: 217-231. PMID 28797972. doi:10.1016/j.colsurfb.2017.07.038.
Machatschek R, Lendlein A (March 2020). «Fundamental insights in PLGA degradation from thin film studies». Journal of Controlled Release 319: 276-284. PMID 31884098. S2CID 209511941. doi:10.1016/j.jconrel.2019.12.044.
Ramot Y, Haim-Zada M, Domb AJ, Nyska A (December 2016). «Biocompatibility and safety of PLA and its copolymers». Advanced Drug Delivery Reviews. PLA biodegradable polymers 107: 153-162. PMID 27058154. doi:10.1016/j.addr.2016.03.012.
Sasaki JI, Abe GL, Li A, Thongthai P, Tsuboi R, Kohno T, Imazato S (May 2021). «Barrier membranes for tissue regeneration in dentistry». Biomaterial Investigations in Dentistry 8 (1): 54-63. PMC 8158285. PMID 34104896. doi:10.1080/26415275.2021.1925556.
Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, Soh BK, Yoon G, Yu D, Yun Y, Lee BK, Jiang X, Wang Y (June 2019). «Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation». Journal of Controlled Release 304: 125-134. PMID 31071374. S2CID 149444044. doi:10.1016/j.jconrel.2019.05.003.
Xiao Q, Zhang H, Wu X, Qu J, Qin L, Wang C (2022). «Augmented Renal Clearance in Severe Infections-An Important Consideration in Vancomycin Dosing: A Narrative Review». Frontiers in Pharmacology 13: 835557. PMC 8979486. PMID 35387348. doi:10.3389/fphar.2022.835557.

restore-surgical.co.uk

«Synthetic Barrier Membrane by Powerbone (Resorbing)». Restore Surgical (en inglés británico). Consultado el 30 de abril de 2023.

semanticscholar.org

api.semanticscholar.org

Abulateefeh SR (February 2023). «Long-acting injectable PLGA/PLA depots for leuprolide acetate: successful translation from bench to clinic». Drug Delivery and Translational Research 13 (2): 520-530. PMID 35976565. S2CID 251622670. doi:10.1007/s13346-022-01228-0.
Astete CE, Sabliov CM (2006). «Synthesis and characterization of PLGA nanoparticles». Journal of Biomaterials Science. Polymer Edition 17 (3): 247-289. PMID 16689015. S2CID 7607080. doi:10.1163/156856206775997322.
Fu K, Pack DW, Klibanov AM, Langer R (January 2000). «Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres». Pharmaceutical Research 17 (1): 100-106. PMID 10714616. S2CID 22378621. doi:10.1023/A:1007582911958.
Elmowafy EM, Tiboni M, Soliman ME (July 2019). «Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles». Journal of Pharmaceutical Investigation (en inglés) 49 (4): 347-380. ISSN 2093-6214. S2CID 256338815. doi:10.1007/s40005-019-00439-x.
Machatschek R, Lendlein A (March 2020). «Fundamental insights in PLGA degradation from thin film studies». Journal of Controlled Release 319: 276-284. PMID 31884098. S2CID 209511941. doi:10.1016/j.jconrel.2019.12.044.
Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, Soh BK, Yoon G, Yu D, Yun Y, Lee BK, Jiang X, Wang Y (June 2019). «Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation». Journal of Controlled Release 304: 125-134. PMID 31071374. S2CID 149444044. doi:10.1016/j.jconrel.2019.05.003.